☆ 4.6 Article

Anticancer Activity of Anti-Tubercular Compound(s) Designed on Pyrrolyl Benzohydrazine Scaffolds: A Repurposing Study

PROCESSES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances

Emilio Mateev et al.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Therapeutic potential of pyrrole and pyrrolidine analogs: an update

N. Jeelan Basha et al.

Summary: The chemistry of nitrogen-containing heterocyclic compound pyrrole and pyrrolidine has been extensively studied due to their diverse biological and medicinal importance. Metal complexes of pyrrole, such as chlorophyll, hemoglobin, myoglobin, and cytochrome, play vital roles in living systems. Additionally, many medicinal drugs are derived from pyrrole, pyrrolidine, or their fused analogs. This review focuses on the therapeutic potential of pyrrole and pyrrolidine, particularly in anticancer, anti-inflammatory, antiviral, and antituberculosis applications. It also summarizes recent reports on pyrrole and pyrrolidine analogs and their biological potential.

MOLECULAR DIVERSITY (2022)

添加到收藏夹

Article Oncology

PLK1 inhibition-based combination therapies for cancer management

Shengqin Su et al.

Summary: This review discusses the role of PLK1 in cancer and the advantages of combining PLK1 inhibitors with other drugs for cancer treatment. PLK1 inhibitors in combination with chemotherapy drugs and targeted small molecules have shown superior effects against cancer both in vitro and in vivo. However, further research is needed to identify the best combination targets and drug combinations.

TRANSLATIONAL ONCOLOGY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Design, synthesis and biological evaluation of novel 2-phenyl-4,5,6,7-tetrahydro-1H-indole derivatives as potential anticancer agents and tubulin polymerization inhibitors

Guangcheng Wang et al.

Summary: A series of new 2-phenyl-4,5,6,7-tetrahydro-1H-indole derivatives were synthesized and evaluated for their anti-proliferative activities, with one compound showing the most potent anticancer activity against breast cancer and lung cancer cells while sparing normal liver cells. Mechanism studies revealed that the compound arrested cell cycle and induced apoptosis, and effectively inhibited tubulin polymerization with an inhibitory mechanism similar to colchicine. Molecular docking studies indicated high binding affinities for the colchicine binding pocket of tubulin, suggesting potential as new tubulin polymerization inhibitors.

ARABIAN JOURNAL OF CHEMISTRY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Drug Repurposing in Cancer Therapy: Influence of Patient's Genetic Background in Breast Cancer Treatment

Rafaela Rodrigues et al.

Summary: Cancer is a leading cause of death worldwide, with breast cancer being the most prevalent type in women. Drug resistance poses a major challenge in breast cancer treatment, leading to high mortality rates. Repurposing drugs and conducting further research and clinical trials are important for improving the effectiveness and personalization of breast cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Oncology

The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future

Yongwei Qin et al.

Summary: Tuberculosis is an important risk factor for the occurrence of lung cancer, and Mycobacterium tuberculosis plays a crucial role in inducing tumor formation and is associated with factors such as age, sex, and smoking.

INFECTIOUS AGENTS AND CANCER (2022)

添加到收藏夹

Review Oncology

Present and Future Perspective on PLK1 Inhibition in Cancer Treatment

Michela Chiappa et al.

Summary: This article summarizes the role of Polo-like kinase 1 (PLK1) in response to DNA damage and discusses the potential applications of PLK1 in cancer treatment.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Respiratory System

Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis

Javier Cabrera-Sanchez et al.

Summary: This study found an association between tuberculosis and the occurrence of lung cancer, particularly in the first 2 years after tuberculosis diagnosis. However, most studies were retrospective and had limitations in controlling confounding factors like passive smoking, environmental exposure, and socioeconomic status.

EUROPEAN RESPIRATORY REVIEW (2022)

添加到收藏夹

Article Chemistry, Analytical

An investigation of Plk1 PBD inhibitor KBJK557 as a tumor growth suppressor in non-small cell lung cancer

Pethaiah Gunasekaran et al.

Summary: This study evaluated the anticancer potential of Plk1 PBD inhibitor KBJK557 against non-small cell lung cancer (NSCLC) cells. KBJK557 showed notable cytotoxic effects and induced G2/M cell cycle arrest and apoptosis. In vivo experiments in a xenograft mice model demonstrated that KBJK557 significantly decreased tumor size, highlighting the importance of Plk1 in lung cancer.

JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY (2022)

添加到收藏夹

Review Medicine, General & Internal

Repurposing approved drugs for cancer therapy

Catherine H. Schein

Summary: Repurposing approved drugs for cancer treatment is a promising strategy to enhance chemotherapy, control side effects, or serve as second-line treatments for resistant tumors. However, lack of understanding of drug mechanisms and issues with patient populations in clinical trials may impact the evaluation of repurposing strategies.

BRITISH MEDICAL BULLETIN (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line

Sushma S. Murthy et al.

Summary: Bromelain extracted from the stem of pineapple has shown high binding affinity with key proteins involved in hepatocellular carcinoma progression, demonstrating potential anti-cancer effects in HepG2 cell lines.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes

Vineela Parvathaneni et al.

Summary: Repurposed drugs show promising efficacy against cancer, with bedaquiline being explored in an inhalable cyclodextrin complex formulation for treating non-small cell lung cancer. The complex demonstrates efficient lung deposition and cytotoxicity, indicating potential for NSCLC treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Mathematical & Computational Biology

Crosstalk between Plk1, p53, cell cycle, and G2/M DNA damage checkpoint regulation in cancer: computational modeling and analysis

Yongwoon Jung et al.

Summary: Different cancer cell lines have varying responses to perturbations, with cells carrying DNA damage checkpoint-related mutations being more sensitive to gene perturbations. A computational model was developed to study the interactions between Plk1, p53, and G2/M DNA damage checkpoint, successfully explaining the phenotypes of different cancer cell lines. The model can be used to predict the effect of potential treatments targeting key regulators on cell cycle progression.

NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)

Suyash M. Patil et al.

Summary: This study developed inhalable BQ-loaded cubosome nanocarriers for NSCLC treatment, showing enhanced therapeutic effects and aerosolization performance compared to free BQ.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics

Alan Talevi et al.

EXPERT OPINION ON DRUG DISCOVERY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of Targeted Covalent Natural Products against PLK1 by Herb-Based Screening

Hao Liang et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

添加到收藏夹

Article Chemistry, Multidisciplinary

Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors

Nashwa M. Saleh et al.

FRONTIERS IN CHEMISTRY (2020)

添加到收藏夹

Article Medicine, General & Internal

Eriodictyol exerts potent anticancer activity against A549 human lung cancer cell line by inducing mitochondrial-mediated apoptosis, G2/M cell cycle arrest and inhibition of m-TOR/PI3K/Akt signalling pathway

Yong Zhang et al.

ARCHIVES OF MEDICAL SCIENCE (2020)

添加到收藏夹

Review Oncology

Molecular and enzoinformatics perspectives of targeting Polo-like kinase 1 in cancer therapy

Shazi Shakil et al.

SEMINARS IN CANCER BIOLOGY (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

An oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication

Syed Mohd. Danish Rizvi et al.

3 BIOTECH (2019)

添加到收藏夹

Article Chemistry, Multidisciplinary

Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents

H. A. Arjun et al.

FRONTIERS IN CHEMISTRY (2019)

添加到收藏夹

Article Materials Science, Biomaterials

Repurposing antitubercular agent isoniazid for treatment of prostate cancer

Qingzhi Lv et al.

BIOMATERIALS SCIENCE (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

3-Chloro-N′-(2-hydroxybenzylidene)benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy

Federica Sarno et al.

FRONTIERS IN PHARMACOLOGY (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Novel glitazones as PPAR agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies

Subhankar P. Mandal et al.

CHEMISTRY CENTRAL JOURNAL (2018)

添加到收藏夹

Article Chemistry, Medicinal

Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors

Shrinivas D. Joshi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

New Tripentone Analogs with Antiproliferative Activity

Barbara Parrino et al.

MOLECULES (2017)

添加到收藏夹

Review Chemistry, Multidisciplinary

Review: biologically active pyrazole derivatives

Anam Ansari et al.

NEW JOURNAL OF CHEMISTRY (2017)

添加到收藏夹

Review Oncology

PLK1, A Potential Target for Cancer Therapy

Zhixian Liu et al.

TRANSLATIONAL ONCOLOGY (2017)

添加到收藏夹

Article Chemistry, Medicinal

Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N′-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides

Awwad A. Radwan et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

添加到收藏夹

Article Chemistry, Medicinal

N′-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential

Pooja R. Kamath et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

添加到收藏夹

Review Oncology

Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics

Rosie Elizabeth Ann Gutteridge et al.

MOLECULAR CANCER THERAPEUTICS (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors

Hai-Chao Wang et al.

MOLECULES (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

A novel anti-microtubule agent with carbazole and benzohydrazide structures suppresses tumor cell growth in vivo

Makoto Ohira et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)

添加到收藏夹

Article Chemistry, Medicinal

Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase

Joonhyeok Choi et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors

Joonhyeok Choi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone

Dennis Falzon et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)

添加到收藏夹

Review Biochemistry & Molecular Biology

Medicinal attributes of pyrazolo[3,4-d]pyrimidines: A review

Monika Chauhan et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

添加到收藏夹

Review Oncology

The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?

Brian D. Cholewa et al.

CANCER RESEARCH (2013)

添加到收藏夹

Article Chemistry, Multidisciplinary

SwissParam: A Fast Force Field Generation Tool for Small Organic Molecules

Vincent Zoete et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)

添加到收藏夹

Article Chemistry, Multidisciplinary

Open Babel: An open chemical toolbox

Noel M. O'Boyle et al.

JOURNAL OF CHEMINFORMATICS (2011)

添加到收藏夹

Article Dermatology

Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells

Travis L. Schmit et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)

添加到收藏夹

Article Chemistry, Physical

GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation

Berk Hess et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure of the catalytic domain of human polo-like kinase 1

Michael Kothe et al.

BIOCHEMISTRY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synthesis and structure-activity relationships of a series of pyrrole cannabinoid receptor agonists

G Tarzia et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2003)

添加到收藏夹

Article Chemistry, Physical

Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K

P Mark et al.

JOURNAL OF PHYSICAL CHEMISTRY A (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.